"MUST READ" Alright $IMMB Investors and Future Investors

New Post Public Reply Private Reply Replies (0) Message Board
MoneyMaker

"MUST READ" Alright $IMMB Investors and Future Investors here is why I just posted a world of info on HIV/AIDS, To show everyone we are sitting on an ABSOLUTE LIFE CHANGER.

Amazing Website >> http://www.immunotechlab.com/


As you can see the market here is wide open for growth and by 2018 will consist of a $21 Billion Industry with a steady growth of 7% per annum. More IMPORTANTLY we are in an transition period where MANY current PATENTS will EXPIRE, leaving the door wide open for IMMB! 

Why is that important to IMMB, there is simply room for Competitors and definite interest for MERGERS/ACQUISITIONS of smaller cap companies. Something in this economy that is happening everyday.

Well here is my take as to WHY you should BUY IMMB.... 

IMMB currently carries a HV/AIDS PATENT valued at over $5 Million >> http://imagehost.vendio.com/a/8709739/view/Patent.png

So we are in the market. Now we need a game plan, well Dr. Harry Zhabilov worked his ass off for many years using his amazing scientific skills to create a patent... IMMB then realizes they can tap into a Billion Dollar Market with his Patents which for the record we have not one but 4 Patents. ...Mr.Zhabilov is an amazing Doctor....but he can't do it on his own so on October of 2012 he makes an even more Brilliant move than his Patent Creation, HE SIGNS a contract with Mr. Bo Linton and appointed him to be part of the Board of Directors .
Well for the people who don't know BO LINTON he has a habit of taking the companies he is involved with to the BIG BOARDS NYSE/NASDAQ)...His last one being MAGNEGAS whom just recently rang the closing bell!

As of February/2013 IMMB made another BIG move, they appointed Mr. Valentin Dimitrov to the board of directors of the company. Mr. Dimitrov is a CEO of M.T. Rose Corporation also Mr. Dimitrov is one of the owners of the second largest chemical plant in Bulgaria, Europe.

So now we have a growing Board with TOP notch Members whom carry HUGE connections.

Still with me, well on November 2012 a HUGE NEWS RELEASE Link Provided >> http://www.otcmarkets.com/stock/IMMB/news
Immunotech Laboratories Inc. Announces Breakthrough Results for HIV and AIDS Treatment for Terminal Salvage Patients

Followed by a much BIGGER News RELEASE JAN/2013 Link Provided >> http://www.otcmarkets.com/stock/IMMB/news
Immunotech Laboratories Announces LOI With International Bio-Tech Partner For USA Clinical Trials Funding Of Patented HIV Medicines 

Which in turn led to THE BIGGEST ONE TO DATE FEB/2013 Link Provided >> Immunotech Laboratories (IMMB) Patented "IPF" Technology A Serious Contender In The Race For HIV & Cancer Cures

If you are still with me you are now adding everything up and saying to yourself HOLY SH*T, We are OFFICIALLY INVOLVED in THAT COVETED BILLION DOLLAR MARKET....and you should be saying IMMB is the MOST UNDERVALUED MEDICAL SCIENCE COMPANY in the OTC soon to be NASDAQ and or NYSE... 


From the last PR and in the words of MR.BO LINTON (read BOLD)>>
Mr. Linton further commented the company recently received an initial inquiry for a significant order of the company's patented HIV vaccine by an International associate for use as an "Experimental Drug". If confirmed the initial order would be in excess of several Million Dollars. This would expand the company's operations from Research & Development to a Bio-Pharma manufacturing company . In Africa, where approved experimental treatments are permitted, there are approximately 30 Million HIV/AIDS patients alone.

Now that you are seeing what I am seeing I will show you the KICKER >> 

CURRENT SHARE STRUCTURE 
OUTSTANDING SHARES 60,500,000 give or take a handful
FLOAT 1 MILLION YES, MILLION (give or take a handful)CONFIRMED Jan.31/2013 in video interview with MR. LINTON (link provided ) >> http://www.otcmarkets.com/stock/IMMB/news
AUTHORIZED 150,000,000

Want More, I have more >>
INSIDERS HOLDINGS 98% of O/S Here is the PROOF >> 
Name of Shareholder Number of Shares
Harry Zhabilov 24,895,646 41.11
Ara Ghanime 24,895,646 41.11
Dow Jones Link 2,773,500 4.58
Allie Chang 600,000 1.0
Paul Felizian 600,000 1.0
Lord George Equities 5,400,000 9.0
Joseph Pittera 250,000 0.41
Harout Tovmasyan 151,000 0.25
Elie Sakayan 50,000 0.08
Hagop Parseghian 600,000 1.0
Others 339,896 0.46

So there you have it!

PS since last Wednesday in case you missed it we have seen LESS than 400,000 Shares TRADED or for the most part BOUGHT and we are up from .06 to .35 with MAJOR NEWS PENDING....with that said we have seen MAJOR BIDS UNTOUCHED where investors could have taken HUGE PERCENTAGE GAINS and SIMPLY REFUSED to knowing where IMMB is heading SHORT TERM and or LONG TERM! 

Good LUCK and REMEMBER only use this as a reference an never spend more than you are willing to lose.

Your Friend Cheeky!

PSS there is more to IMMB than HIV/AIDS Please go to WEBSITE and absorb as much as you can, They are diversified to say the least...link provided above!

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hair Syrup's Big U.S. Leap: Target Welcomes Viral Brand

Updated Category News Views 2

From Kitchen Experiment to U.S. Debut Here's a story that barely fits the tight mold of your typical business textbook. Hair Syrup, born from the brain of a university student tinkering at her kitchen table, is about to make waves across the pond. Lucie Macleod did what many dream of—she took a DIY hair oil project and spun it into a multimillion-dollar brand, now set...

Continue Reading
Health Net's $2M Boost for Stanislaus Affordable Housing

Updated Category News Views 1

Joining the Fight Against California’s Housing Crisis Well, I'll be the first to say it's a breath of fresh air when a healthcare beast like Health Net starts investing in something as critical as affordable housing. This is no drop in the bucket—two million dollars is quite the commitment to fix some of the mess that’s been brewing in Stanislaus County, California....

Continue Reading
Sacrifice Unending: 9/11's Lingering Health Toll

Updated Category News Views 0

The Unseen Toll of 9/11 on the Firefighter Community Two and a half decades since that fateful morning of September 11, 2001, we're staring at a grim reality. The heroic souls of the New York City Fire Department (FDNY)—those who ran toward peril when others ran away—are still paying the price. Incredibly, more than 400 FDNY members have succumbed to World Trade...

Continue Reading
Woodpack Global Unveils Crate Design System: A New Era Begins

Updated Category News Views 1

Innovating the Wooden Crate Landscape An old industry got a much-needed facelift today, folks. Woodpack Global has rolled out Crate Design System™ (CDS)—a snazzy new tool that's shaking up the wooden crate design landscape. It blows the dust off outdated design methods that have been collecting cobwebs since the '60s. That's right, we’re talking about a significant...

Continue Reading
Shareholder Rights in Focus: Examining Key Buyouts

Updated Category News Views 0

Shareholder Concerns Rise Amid Corporate Buyouts The stakes are high for the shareholders of Distribution Solutions Group, Eagle Financial Services, Safety Insurance Group, and Utz Brands as their companies face potential buyouts. Let's chew over what's on the table: the sweet deals insiders might score and the legal maneuvers in play. Halper Sadeh LLC, a heavy-hitting...

Continue Reading
Push Notification Security Transforms Healthcare IT Support

Updated Category News Views 1

Cutting the Fat on IT Help Desk Bottlenecks Healthcare IT teams are fighting an uphill battle with password resets, a mundane task consuming up to half of all help desk calls. It's like trying to stop a leaking dam with duct tape. For health systems, these calls aren't just a minor annoyance—they're a full-fledged budget hog. Try telling a CIO that an agent-friendly...

Continue Reading
Aflac's $200M Milestone in Cancer Charity Support

Updated Category News Views 0

Pioneering Efforts Across Decades Here’s an effort that bucks the usual corporate talk. Aflac, the supplemental insurance giant, isn’t just mumbling about its mission; it's doing the heavy lifting in the fight against childhood cancer and blood disorders. With over $200 million in contributions poured into the cause over more than 30 years, they're putting the capital...

Continue Reading
EFSI Shareholders on Alert Amid M&A Deal Scrutiny

Updated Category News Views 3

Eagle Financial Services Under the Microscope A buzz is picking up in the world of mergers and acquisitions, and this time, it's Eagle Financial Services, Inc. (NASDAQ: EFSI) caught in the crosshairs. What's the chatter all about? Well, it looks like Juan Monteverde and his crew over at Monteverde & Associates PC have set their sights on Eagle's proposed sale to John...

Continue Reading
RevSystems Joins Elite OpenAI Partner Network

Updated Category News Views 1

RevSystems Inks Deal with OpenAI Partner Network In the latest shuffle of the AI advisory deck, RevSystems just found itself elbowing into the exclusive OpenAI Partner Network. Based out of New York, RevSystems has carved a niche by spinning tech wizardry into tangible business results. Their new status as an OpenAI Select Partner puts them on a playing field where AI...

Continue Reading
CUBEX Lights Up Veterinary Care with Mini Essential

Updated Category News Views 5

Inventory Woes? Meet Mini Essential If you’ve ever worked in or around veterinary hospitals, you know the old-school headaches of managing controlled substances. Picture this: piles of paper logs, end-of-shift recounting, and inevitable discrepancies that rear their ugly heads long after closing time. Enter CUBEX, shaking things up with their latest launch, Mini...

Continue Reading

Top 5 Most Recently Viewed Articles

Alphyn Biologics Launches Groundbreaking Atopic Dermatitis Trial

Updated Category News Views 324

Alphyn Biologics Unveils Innovative Clinical Trial for Atopic Dermatitis Treatment Alphyn Biologics, Inc. is making strides in its mission to address the complexities of atopic dermatitis (AD) by launching the CLEAR-AD1 Phase 2b clinical trial program. Leading this initiative is their cutting-edge product, Zabalafin Hydrogel, which is designed to effectively target the...

Continue Reading
CoreWeave Faces Market Struggles Amid AI Demand Surge

Updated Category News Views 120

CoreWeave Inc Experiences Major Stock Drop CoreWeave Inc (NASDAQ: CRWV) has seen its stock plummet by nearly 10% in pre-market trading, marking a significant moment for the company. The drop comes despite the firm reporting strong second-quarter revenue that outstrips projections. However, the downside appears to be linked to disappointing earnings per share (EPS), which...

Continue Reading
DeepSeek's Impact on AI: Rethinking Market Dynamics

Updated Category News Views 326

Understanding DeepSeek's Revolutionary AI Tools In today's rapidly evolving technological landscape, a recent development has the potential to change the rules of the game. While debates about software consuming the world continue, it's crucial to delve into the implications of DeepSeek's innovative approach. This situation may echo the historical context of the Soviet...

Continue Reading
Strategic Communications Secures Major National Contract

Updated Category News Views 123

Strategic Communications Awarded National Sourcewell Contract Strategic Communications has recently achieved a vital milestone by securing a national Sourcewell contract tailored specifically for Public Safety Software-as-a-Service (SaaS), Infrastructure-as-a-Service (IaaS), Platform-as-a-Service (PaaS), and various other professional technology services. This cooperative...

Continue Reading
Porter's Innovative Care Solutions Transform Member Health

Updated Category News Views 312

Porter Simplifying Health Care Coordination Porter has emerged as a pioneering force in AI-driven care coordination and comprehensive clinical services at home. With a focus on Medicare Advantage, ACA Commercial, and Medicaid plans, Porter stands out as an essential in-home vendor. By integrating care coordination, in-home visits, and advanced analytics, this innovative...

Continue Reading